|
Active substance |
Venetoclax |
|
Holder |
AbbVie |
|
Status |
Closed |
|
Indication |
Treatment of chronic lymphocytic leukaemia in adult patients who are unsuitable for or have failed other treatments. |
|
Public documents |
|
|
Last update |
15/12/2017 |
Venclyxto®
Last updated on 10/09/2024